Skip to main content

Advertisement

SpringerLink
Log in

Axonal form of Guillain-Barré syndrome in a patient receiving oxaliplatin-based chemotherapy

  • Letter to the Editor
  • Published:
Neurological Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Milants C, Benmouna K, Wang FC (2017) iMAX: a new tool to assess peripheral motor axonal hypoexcitability. Clin Neurophysiol 128(12):2382–2383

    Article  Google Scholar 

  2. Uncini A, Susuki K, Yuki N (2013) Nodo-paranodopathy: beyond the demyelinating and axonal classification in anti-ganglioside antibody-mediated neuropathies. Clin Neurophysiol 124(10):1928–1934

    Article  Google Scholar 

  3. Lehky TJ, Leonard GD, Wilson RH, Grem JL, Floeter MK (2004) Oxaliplatin-induced neurotoxicity: acute hyperexcitability and chronic neuropathy. Muscle Nerve 29(3):387–392

    Article  CAS  Google Scholar 

  4. Heide R, Bostock H, Ventzel L, Grafe P, Bergmans J, Fuglsang-Frederiksen A, Finnerup NB, Tankisi H (2018) Axonal excitability changes and acute symptoms of oxaliplatin treatment: in vivo evidence for slowed sodium channel inactivation. Clin Neurophysiol 129:694–706

    Article  Google Scholar 

  5. Argyriou AA, Cavaletti G, Antonacopoulou A, Genazzani AA, Briani C, Bruna J, Terrazzino S, Velasco R, Alberti P, Campagnolo M, Lonardi S, Cortinovis D, Cazzaniga M, Santos C, Psaromyalou A, Angelopoulou A, Kalofonos HP (2013) Voltage-gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin-induced peripheral neurotoxicity. Cancer 119:3570–3577

    Article  CAS  Google Scholar 

  6. Hadden RD, Karch H, Hartung HP, Zielasek J, Weissbrich B, Schubert J, Weishaupt A, Cornblath DR, Swan AV, Hughes RA, Toyka KV, Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group (2001) Preceding infections, immune factors, and outcome in Guillain-Barré syndrome. Neurology 56(6):758–765

    Article  CAS  Google Scholar 

  7. Christodoulou C, Anastasopoulos D, Visvikis A, Mellou S, Detsi I, Tsiakalos G, Pateli A, Klouvas G, Papadimitriou A, Skarlos DV (2004) Guillain-Barré syndrome in a patient with metastatic colon cancer receiving oxaliplatin-based chemotherapy. Anti-Cancer Drugs 15(10):997–999

    Article  CAS  Google Scholar 

  8. Jaso R, Sierre M, Calleja J, Valero C, Pascual J (2010) Guillain-Barré syndrome after rituximab in a patient with idiopathic thombocytopenic purpura: a causal association? J Neurol 257(3):488–489

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Neurophysiology, University of Liège, B35, 4000, Liège, Belgium

    Maelle Tyberghein, Christophe Milants, Olivier Bouquiaux & François Wang

Authors
  1. Maelle Tyberghein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christophe Milants
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Olivier Bouquiaux
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. François Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to François Wang.

Ethics declarations

Ethical approval

All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from the participant included in the paper.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tyberghein, M., Milants, C., Bouquiaux, O. et al. Axonal form of Guillain-Barré syndrome in a patient receiving oxaliplatin-based chemotherapy. Neurol Sci 41, 1611–1613 (2020). https://doi.org/10.1007/s10072-019-04199-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-019-04199-2

Search

Navigation